Product Information
FYAVOLV 0.5 MG-2.5 MCG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.9127 per EA under NDC 68180082773. Its NADAC has been published 300 times since Jan 6, 2021.
FDA first approved this application on Dec 10, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.0025; .5 mg/1; mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180082773
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA204213FDA Approved
12/10/2015
TE Code
AB
On Market Since
3/15/2016
Price Statistics
The NADAC for FYAVOLV 0.5 MG-2.5 MCG TABLET has been published 300 times since Jan 6, 2021, and over the history we have for it it has declined 18.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9127 per EA |
|---|---|
| All-time high | $2.8173 (Jul 14, 2021) |
| All-time low | $0.6551 (Jun 17, 2026) |
| 52-week high | $1.0935 |
| 52-week low | $0.6551 |
| Median price | $1.2073 |
| Average price | $1.2760 |
| Largest weekly change | +124.6% (Apr 21, 2021) |
| Weeks tracked | 300 |
| Tracking since | Jan 6, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FYAVOLV 0.5 MG-2.5 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FYAVOLV 0.5 MG-2.5 MCG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.9127 per EA (NDC 68180082773), effective Sep 30, 2026.
How has the price of FYAVOLV 0.5 MG-2.5 MCG TABLET changed over time?
Over the history we have for it, the NADAC for FYAVOLV 0.5 MG-2.5 MCG TABLET has declined 18.6%. It has been tracked across 300 weekly CMS publications since Jan 6, 2021.
What are the highest and lowest recorded NADAC prices for FYAVOLV 0.5 MG-2.5 MCG TABLET?
Since Jan 6, 2021, the NADAC for FYAVOLV 0.5 MG-2.5 MCG TABLET has ranged from a low of $0.6551 (Jun 17, 2026) to a high of $2.8173 (Jul 14, 2021), with a median of $1.2073 per EA.
Are there cheaper alternatives to FYAVOLV 0.5 MG-2.5 MCG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FYAVOLV 0.5 MG-2.5 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FYAVOLV 0.5 MG-2.5 MCG TABLET?
FYAVOLV 0.5 MG-2.5 MCG TABLET (NDC 68180082773) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.